Open AccessPhase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer
Author(s) -
Tadashi Uwagawa,
Taro Sakamoto,
Takeshi Gocho,
Hiroaki Shiba,
Shinji Onda,
Jungo Yasuda,
Yoshio Shirai,
Ryoga Hamura,
Kenei Furukawa,
Katsuhiko Yanaga,
Toru Ikegami
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0267623
Subject(s) - medicine , gemcitabine , regimen , pancreatic cancer , chemotherapy regimen , chemotherapy , folfirinox , gastroenterology , erlotinib , phases of clinical research , surgery , cancer , irinotecan , colorectal cancer , epidermal growth factor receptor